March 20, 2019
Worldwide eClinical solutions market is forecast to surpass a revenue of USD 12,985 MN by 2026, according to the latest research available with Market Study Report LLC. Rising number of clinical database and stringent regulatory guidelines to ensure accurate and timely clinical results will majorly drive the market demand, as per the study.
A large number of pharmaceutical organizations have deployed eClinical solution software to adhere to the regulatory norms regarding error free clinical data processing. As per the ALCOA standard, electronic clinical outcome assessment is a mandate in clinical trials, as the results obtained from these devices and gadgets are claimed to be highly productive, accurate, and time-saving.
The increasing number of clinical research activities for the development of novel drugs have further provided a substantial impetus to the eClinical solutions market share, as per the study. Drug approval processes have received a considerable funding by the government entities over the recent years. Clinical data management system stands as a pivotal segment driven by the trend and is being adopted widely to process the queueing molecules in development phase, cites the report.
The report provides an in-depth analysis of the eClinical solutions market drivers, restraints, and opportunities over the forecast period. A deep dive analysis of the report in terms of end-users, products & solutions, regional landscape, clinical trials, and deployment method, and competitive profiling has also been detailed in the report.
Request Sample Copy of This report @ https://www.marketstudyreport.com/request-a-sample/1695040/
Some of the key findings of the report include:
The competitive landscape of eClinical solutions market comprises organizations such as Oracle Corporation, Medidata Solution, Inc, Parexel International Corporation, DataTrak International, Inc, OmniComm Systems, CRF Health. eResearch Technology, BioClinica Inc., eClinical Solutions, Inc, PHT Corporation, etc. An overview of the financials, product benchmarking, and recent developments by these companies have been profiled in this report. The study cites mergers & acquisitions, R&D toward development of innovative products, and expansion strategies to majorly characterize the competitive landscape